AVROBIO, Inc.

AVRO | NASDAQ | 0 Followers
$1.40 -1.41% -$0.02
Follow
Loading...

Profile

AVROBIO, Inc. (AVRO) is a biotechnology company focused on the development and commercialization of therapeutic therapies based on gene therapy and cell therapy. The company concentrates on developing innovative treatment approaches for genetic diseases and rare conditions. AVROBIO is working on personalized treatment strategies that involve modifying a patient's own cells and genes to treat diseases. With the growing emphasis on advanced treatment methods and gene therapy, AVROBIO, Inc. has the potential for sustained growth. AVROBIO, Inc. (AVRO) shares might be an interesting choice for investors seeking involvement in the biotechnology and therapeutic therapies industry.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade